# Validity and Reliability Evaluation of the PRO-CTCAE for Adult-type Diffuse Gliomas Patients in Chinese Population

> **NCT05486923** · — · COMPLETED · sponsor: **Huashan Hospital** · enrollment: 450 (actual)

## Conditions studied

- Glioma
- Patient Reported Outcome Measures
- Self Report
- Adverse Effects

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05486923
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-19
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-02-01
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2025-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05486923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05486923, "Validity and Reliability Evaluation of the PRO-CTCAE for Adult-type Diffuse Gliomas Patients in Chinese Population". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05486923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*